StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)

Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%

LeMaitre Vascular total assets

Total assets on the balance sheet at the end of each period.

LeMaitre Vascular's total assets was $640.55M at Jun 30, 2026. For fiscal 2025 it was $615.69M, up 11.6% from the year before. Over ten years it grew 21.1% a year on average. The highest annual figure on record is $615.69M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$615.69M+11.6%
FY2024Dec 31, 2024$551.82M+59.1%
FY2023Dec 31, 2023$346.78M+11.7%
FY2022Dec 31, 2022$310.48M+6.0%
FY2021Dec 31, 2021$292.80M+15.8%
FY2020Dec 31, 2020$252.81M+34.2%
FY2019Dec 31, 2019$188.34M+23.0%
FY2018Dec 31, 2018$153.09M+21.2%
FY2017Dec 31, 2017$126.32M+23.9%
FY2016Dec 31, 2016$101.92M+12.4%
FY2015Dec 31, 2015$90.70M+11.3%
FY2014Dec 31, 2014$81.49M+15.6%
FY2013Dec 31, 2013$70.49M+11.8%
FY2012Dec 31, 2012$63.06M+5.7%
FY2011Dec 31, 2011$59.69M-5.7%
FY2010Dec 31, 2010$63.27M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$640.55M+10.9%
Q1 FY2026Mar 31, 2026$629.53M+13.2%
Q4 FY2025Dec 31, 2025$615.69M+11.6%
Q3 FY2025Sep 30, 2025$598.07M+58.6%
Q2 FY2025Jun 30, 2025$577.59M+59.1%
Q1 FY2025Mar 31, 2025$556.01M+57.1%
Q4 FY2024Dec 31, 2024$551.82M+59.1%
Q3 FY2024Sep 30, 2024$377.03M+12.9%
Q2 FY2024Jun 30, 2024$363.08M+11.2%
Q1 FY2024Mar 31, 2024$353.96M+12.4%
Q4 FY2023Dec 31, 2023$346.78M+11.7%
Q3 FY2023Sep 30, 2023$334.01M+10.6%
Q2 FY2023Jun 30, 2023$326.47M+9.0%
Q1 FY2023Mar 31, 2023$314.87M+7.7%
Q4 FY2022Dec 31, 2022$310.48M+6.0%
Q3 FY2022Sep 30, 2022$302.05M+4.3%
Q2 FY2022Jun 30, 2022$299.43M+21.5%
Q1 FY2022Mar 31, 2022$292.45M+18.2%
Q4 FY2021Dec 31, 2021$292.80M+15.8%
Q3 FY2021Sep 30, 2021$289.47M+10.7%
Q2 FY2021Jun 30, 2021$246.51M-3.6%
Q1 FY2021Mar 31, 2021$247.37M+34.0%
Q4 FY2020Dec 31, 2020$252.81M+34.2%
Q3 FY2020Sep 30, 2020$261.57M+53.9%
Q2 FY2020Jun 30, 2020$255.72M+57.2%
Q1 FY2020Mar 31, 2020$184.56M+15.2%
Q4 FY2019Dec 31, 2019$188.34M+23.0%
Q3 FY2019Sep 30, 2019$170.01M+17.8%
Q2 FY2019Jun 30, 2019$162.66M+18.6%
Q1 FY2019Mar 31, 2019$160.25M+23.8%
Q4 FY2018Dec 31, 2018$153.09M+21.2%
Q3 FY2018Sep 30, 2018$144.33M+19.0%
Q2 FY2018Jun 30, 2018$137.10M+22.4%
Q1 FY2018Mar 31, 2018$129.41M+21.5%
Q4 FY2017Dec 31, 2017$126.32M+23.9%
Q3 FY2017Sep 30, 2017$121.27M+19.7%
Q2 FY2017Jun 30, 2017$112.05M–
Q1 FY2017Mar 31, 2017$106.52M–
Q4 FY2016Dec 31, 2016$101.92M–
Q3 FY2016Sep 30, 2016$101.31M–

More LeMaitre Vascular figures

See a number that looks wrong?